" class="no-js "lang="en-US"> Susan Hertzberg - Medtech Alert
Monday, November 11, 2024
Susan Hertzberg

Susan Hertzberg

About Susan Hertzberg

Susan is an innovative and successful healthcare executive with over 30 years of diagnostics, products, and services experience. She joined BrainScope in June of 2019.

Most recently, Susan was Chief Executive Officer of private equity-backed Prelude Fertility, a comprehensive fertility services company. In just two years, Susan drove the commercial strategy, built the team, and created the largest and fastest-growing fertility services company in the country with over 28 locations in 14 states. She also completed a first of its kind deal with NYU Langone. Prelude completed a merger with Inception Fertility in April of 2019.

Prior to BrainScope, Susan led and scaled several other successful venture/PE funded start-ups.  Leveraging her extensive history and deep knowledge of the diagnostic products and services market, she guided the strategy and execution of these companies and introduced new innovative technologies that have become standard tools in healthcare. Susan’s mission and performance driven leadership style has led to a significant positive impact on the lives of millions of patients and has helped create significant value for her shareholders.

Susan began her career at Quest Diagnostics and spent time at Oxford Health Plans and Abbott Diagnostics before taking on her first role as a CEO. In 2014, she was named an EY Entrepreneur of the Year.  Susan received an MBA from Columbia Business School and a BA in Psychology from Clemson University.  She serves on the board of directors of BreastCancer.Org and is a native New Yorker.

Related Story

Tri-anim Health Services Announces Exclusive Relationship to Distribute Brainscope's Breakthrough Technology for Mild Head Injury Including Concussion, Into Emergency Departments

September 7 2022

Tri-anim Health Services, a specialty distributor of respiratory, anesthesia and critical care products and therapies, […]